Document Detail

Effects of sevoflurane and propofol on cultured bone-marrow mesenchymal stem cells of rats.
MedLine Citation:
PMID:  23380427     Owner:  NLM     Status:  Publisher    
Objective: Bone marrow mesenchymal stem cell (BMSC) is a potentially effective vehicle for the cell and gene therapy in clinical disease treatment. We studied whether the most commonly used anesthetic drugs have negative effects on rat BMSCs in vitro. Materials and methods: The cultured BMSCs were treated with sevoflurane (in 1.7%, 2.3%, and 3%); propofol (5 μg/ml, 10 μg/ml and 20 μg/ml); or 2.3% sevoflurane plus 10 μg/ml propofol. After 4-hour treatment, the cultured BMSCs were prepared for MTT reduction assays and cell morphology observation. Results: Compared to the controls, the 4-hour sevoflurane exposure resulted in decreased cell viability of BMSCs in a concentration-dependent manner; however, 1.7% sevoflurane did not reduce the cell viability. The 4-hour propofol treatment did not affect the cell viability; but combined usage of 2.3% sevoflurane and 10 μg/ml propofol decreased cell viability. In BMSCs treated with higher concentration of sevoflurane (1.7% and 2.3%) and combined usage of the two anesthetics, the cell became raritas with wizened cytoplasm and had fewer connections to each other of BMSCs. More than 2.3%, or 2.3% sevoflurane plus 10 μg/ ml propofol caused cytotoxicity to BMSCs. However, propofol up to 20 μg/ml did not harm the BMSCs. Conclusions: The study indicates that it is necessary to choose the right anesthesia during the BMSCs transplantation therapy.
Xue Zhou; Ying-Qin Li; Wen He; Xiao-Yu Yang; Fa-Huan Song; Zhi-Bin Zhou; Ying Tang; Xia Feng; Li-Hua Zhou
Related Documents :
24300027 - Cathepsin s inhibition suppresses systemic lupus erythematosus and lupus nephritis beca...
22970907 - Challenges enrolling patients with acute ischemic stroke into cell therapy trials.
24691277 - Intrinsic defect in b-lymphoblastoid cell lines from patients with x-linked lymphoproli...
25015277 - Ex vivo generation of murine il-10-producing b cells by fusokines.
10869567 - Cellular glucose-6-phosphate dehydrogenase (g6pd) status modulates the effects of nitri...
19074097 - Prognosis and primary therapy in peripheral t-cell lymphomas.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-5
Journal Detail:
Title:  International journal of clinical pharmacology and therapeutics     Volume:  -     ISSN:  0946-1965     ISO Abbreviation:  Int J Clin Pharmacol Ther     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423309     Medline TA:  Int J Clin Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of the pharmacokinetic interaction between ticagrelor and tolbutamide, a cytochrome P450 ...
Next Document:  Pharmacokinetic comparison of two 4 mg tablet formulations of tizanidine.